Learn more: Prevention & Health Promotion
Through its synergistic activation of GLP-1, GIP, and Glucagon receptors , it provides unique insights into the hormonal regulation of energy balance, fat metabolism, and appetite control
This is particularly important, considering that Pfizer (NYSE: PFE) recently discontinued its oral GLP-1 treatment because of these issues
Ethics declarations Human Ethics and Consent to Participate Not applicable
Positive lipid outcomes have been demonstrated in several of the critical trials that established the cardiovascular benefits of tirzepatide and semaglutide (Table 1
However, challenges including high costs exceeding $1000 per month, gastrointestinal side effects, nutritional deficiencies, and low long-term adherence with subsequent weight regain [5] [6] warrant careful consideration